Literature DB >> 13896855

Exit poliomyelitis--what next?

S GARD.   

Abstract

Entities:  

Keywords:  POLIOMYELITIS/epidemiology

Mesh:

Year:  1961        PMID: 13896855      PMCID: PMC2605057     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


× No keyword cloud information.
  3 in total

1.  Fatal bulbospinal paralytic poliomyelitis due to ECHO 11 virus.

Authors:  A J STEIGMAN; M M LIPTON
Journal:  JAMA       Date:  1960-09-10       Impact factor: 56.272

2.  Seroimmune patterns for poliomyelitis in Sweden.

Authors:  G OLIN; T WESSLEN
Journal:  Arch Gesamte Virusforsch       Date:  1957

3.  Studies of active immunogenesis in poliomyelitis. I. Persistence and recall by homotypic or heterotypic superinfection of neutralizing antibody originally induced in chimpanzees by vaccination or infection.

Authors:  H A HOWE
Journal:  Am J Hyg       Date:  1954-11
  3 in total
  6 in total

1.  IMMUNITY TO POLIOMYELITIS.

Authors:  G DICK
Journal:  Br Med J       Date:  1963-12-07

2.  The influence of previous vaccination with killed vaccine on the susceptibility of the alimentary tract to infection with poliomyelitis virus.

Authors:  J B WILTERDINK; J D VERLINDE
Journal:  Arch Gesamte Virusforsch       Date:  1963

3.  Epidemic of poliomyelitis in Puerto Rico, 1960.

Authors:  R A TIMOTHEE; L MORRIS; M FELIBERTI; L E MAINARDI
Journal:  Public Health Rep       Date:  1963-01       Impact factor: 2.792

4.  A survey of enteroviruses and adenoviruses in the faeces of normal children aged 0-4 years. A report of the Public Health Laboratory Service and the Society of Medical Officers of Health.

Authors:  N S Galbraith
Journal:  J Hyg (Lond)       Date:  1965-12

5.  EPIDEMIOLOGY OF POLIOMYELITIS AND ALLIED DISEASES--1963.

Authors:  D M HORSTMANN
Journal:  Yale J Biol Med       Date:  1963-08

6.  Polio immunization policy in the United States: a new challenge for a new generation.

Authors:  D Salk
Journal:  Am J Public Health       Date:  1988-03       Impact factor: 9.308

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.